ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic r…
Medical - Devices
US, Solana Beach [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about ClearPoint Neuro, Inc.'s gradings, price targets and earnings estimates. None
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2015 | -3.0600 | -4.400 | 3 | 4 | -4 | -108 | -3 | -2 | -9 | -2 | 8 | 3 |
| 2016 | -4.4800 | -3.200 | 4 | 5 | -8 | -78 | -6 | -3 | -7 | -4 | 8 | 5 |
| 2017 | -2.9300 | -2.000 | 5 | 9 | -8 | -49 | -6 | -5 | -7 | -6 | 7 | 8 |
| 2020 | -0.4900 | -0.460 | 11 | 12 | -6 | -11 | -4 | -7 | -4 | -8 | 9 | 11 |
| 2021 | -0.5700 | -0.680 | 12 | 16 | -9 | -16 | -4 | -10 | -6 | -11 | 10 | 14 |
| 2022 | -0.7400 | -0.705 | 16 | 20 | -15 | -17 | -12 | -13 | -13 | -13 | 15 | 18 |
| 2023 | -0.6800 | -0.913 | 20 | 23 | -16 | -22 | -15 | -15 | -16 | -16 | 18 | 21 |
| 2024 | -0.9000 | -0.672 | 23 | 31 | -22 | -16 | -20 | -20 | -22 | -21 | 24 | 28 |
| 2025 | - | -0.584 | - | 38 | - | -14 | - | -24 | - | -26 | - | 35 |
| 2026 | - | 0.F9X/td> | - | 0.F9X/td> | - | 0.F9X/td> | - | 0.F91/td> | - | 0.F91 | - | 0.F91 |